Regulatory agencies are watching closely but have so far largely stayed silent on well-behaved GLP-1 claims, focusing their actions on clear violations (e.g
Regarding article, Heart failure, saxagliptin, and diabetes mellitus: observations from the SAVOR-TIMI 53 randomized trial
During 72 weeks of treatment, people taking tirzepatide at doses of 5, 10, or 15 mg lost an average of 15.0%, 19.5%, and 20.9%, respectively, compared with just 3.1% in people taking a placebo
Stratification based on CKM profiles may help identify individuals most likely to benefit [83]
This combined approach supports long-term weight management by fostering healthier habits and coping strategies
Placebo condition was removed, as THC concentrations were steady, as expected, during the placebo sessions